Table 3.
Obstacles and barriers specific to EU13 countries
| Question | Year | |||
|---|---|---|---|---|
| Topic | Barrier | % detected in 2020 | % detected in 2021 | % detected in 2023 |
| Development, improvement and translation of RD research results | Funding | 83% | 89% | 90% |
| Difficulties in accessing to national resources for funding of research and development of RD projects | 50% | 56% | 80% | |
| Lack of options for exploitation of research results at national level | 50% | 40% | 20% | |
| Language | 17% | 11% | 0% | |
| Participation in EU/international projects in the RD field | Limited links to potential partners | 100% | 78% | 40% |
| Lack of information on funding opportunities | 67% | 56% | 40% | |
| Bureaucratic application on responding procedures | 50% | 50% | 80% | |
| Quality of support provided by national contact points | 50% | 44% | 50% | |
| Limited skills on drafting proposals | 33% | 22% | – | |
| Irrelevance of programme topics and goals to own research agenda | 17% | 22% | 10% | |
% detected % of countries finding the barrier present, – not asked that year, RD rare diseases